STAT3 and hepatocellular carcinoma: CIMO down-regulates constitutively active and inducible upstream kinases (STAT3) and the expression of target genes in vitro and in vivo and enhances cytotoxicity and deletes the nuclear pool of STAT3 in HCC (Table 1).